Clinical Trials Logo

Clinical Trial Summary

Prelabour rupture of membranes (PROM) is associated with intrauterine infection and maternal and neonatal consequences. This risk increases with the length of time from PROM to delivery. Induction of labor has been shown to reduce the rates of those complications, however the optimal time interval has not yet been determined. The main purpose of this single-center randomized prospective study is to assess the differences between two approaches of managing PROM at term-expectant management and induction with a dinoprostone vaginal delivery system.


Clinical Trial Description

Women with singleton pregnancy in cephalic presentation at term (37-41 6/7 weeks gestational age) will be randomised 4 to 12 hours after PROM when a sterile vaginal exam will be completed to assign Bishop score. When Bishop score at presentation will be ≤5, the study will be presented to the patient. Once the patient will be consented and randomized, women will receive dinoprostone vaginal delivery system (for up to 24 hours after randomisation) or will be managed expectantly (for up to 24 hours after randomisation). Patients randomized to the expectant management group will be admitted to the maternity ward, where they will wait up to a maximum of 24 hours for labor to start spontaneously. Patients in the induction group will also be admitted to the maternity ward and induced with a dinoprostone vaginal delivery system. If not removed sooner, the vaginal delivery system will be removed after 24h. If patients in both groups will not be in active labor 24 hours after randomisation they will be admitted to the delivery room and health care providers will manage active labor per usual practice. The need for cesarean section or operative delivery or will be at the discretion of the healthcare provider. In the days following birth, woman in both groups, will be asked to fill in a questionnaire about their satisfaction with the labour experience. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05430711
Study type Interventional
Source University Medical Centre Ljubljana
Contact Polona Peclin
Phone 0038615526162
Email polona.peclin@kclj.si
Status Not yet recruiting
Phase Phase 4
Start date June 2022
Completion date July 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05333731 - Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
Recruiting NCT04558996 - Spanish Registry of Pregnant Women With COVID-19
Recruiting NCT03399266 - Balloon Induction of Labor in PROM for TOLAC N/A
Not yet recruiting NCT00294242 - Safety Study of Membrane Sweeping in Pregnancy Phase 3
Completed NCT05215873 - Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol Phase 4
Recruiting NCT04143685 - Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes N/A